Iovanace Biotherapeutics (IOVA) PT Raised to $10 at TD Cowen

August 25, 2026 7:38 AM

TD Cowen analyst Nicholas Lorusso raised the price target on Iovanace Biotherapeutics (NASDAQ: IOVA) to $10.00 (from $7.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found